- Datametrex (DM) subsidiary Medi-Call MD has launched in-person patient care services in Vancouver
- Medi-Call is an enhanced telemedicine company providing technology-driven e-health and m-health care services
- Certified physicians can now examine patients via Medi-Call’s mobile app and be dispatched to patients’ residences or places of work for additional care
- Once the service is nationalized, patients will be able to be matched with a physician in any location in Canada
- Datametrex AI Limited helps companies fulfill their operational goals through predictive and preventive technologies
- Datametrex (DM) is down by 2.78 per cent and is currently trading at $0.175 per share
Datametrex (DM) subsidiary Medi-Call MD has launched in-person patient care services in Vancouver.
Medi-Call is an enhanced telemedicine company providing technology-driven e-health and m-health care services.
Certified physicians are now able to examine patients via Medi-Call’s mobile app and be dispatched to patients’ residences or places of work to administer additional care.
Patients can also schedule appointments through the app and track a doctor’s journey in real-time.
The service, which will eventually expand across the country, aims to make health care accessible to people in rural or isolated communities, as well as to those with limited time, mobility or transportation choices.
Marshall Gunter, Datametrex’s CEO, sat down with Caroline Egan to provide an update on the app.
“Medi-Call is committed to preserving ongoing continuity of care and the highest clinical standards. Patients will have the option of requesting their favourite providers, but if time is of critical importance on a given day, the nearest provider, even if different, will have full access to all their medical history through the safe and secure electronic medical record-keeping system regardless of visit location, even if it is in a different city. So, in essence, a patient’s doctor’s office will for the first time travel with the client throughout Canada.”
Datametrex AI Limited helps companies fulfill their operational goals through predictive and preventive technologies.
Datametrex (DM) is down by 2.78 per cent and is currently trading at $0.175 per share as of 11:19 am ET.